Ingalls & Snyder LLC’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.6M | Buy |
730,345
+22,248
| +3% | +$582K | 0.48% | 43 |
|
|
2026
Q1 | $19.9M | Sell |
708,097
-9,885
| -1% | -$263K | 0.7% | 34 |
|
|
2025
Q4 | $17.9M | Sell |
717,982
-16,829
| -2% | -$424K | 0.66% | 37 |
|
|
2025
Q3 | $18.7M | Sell |
734,811
-20,502
| -3% | -$506K | 0.61% | 32 |
|
|
2025
Q2 | $18.3M | Buy |
755,313
+110,393
| +17% | +$2.57M | 0.65% | 30 |
|
|
2025
Q1 | $16.3M | Buy |
644,920
+2,815
| +0.4% | +$73.7K | 0.54% | 33 |
|
|
2024
Q4 | $17M | Buy |
642,105
+20,666
| +3% | +$561K | 0.67% | 36 |
|
|
2024
Q3 | $18M | Sell |
621,439
-395
| -0.1% | -$11.5K | 0.7% | 33 |
|
|
2024
Q2 | $17.4M | Sell |
621,834
-1,098
| -0.2% | -$30.2K | 0.75% | 34 |
|
|
2024
Q1 | $17.3M | Buy |
622,932
+46,130
| +8% | +$1.28M | 0.76% | 36 |
|
|
2023
Q4 | $16.6M | Sell |
576,802
-25,951
| -4% | -$784K | 0.75% | 32 |
|
|
2023
Q3 | $20M | Buy |
602,753
+4,103
| +0.7% | +$145K | 0.96% | 25 |
|
|
2023
Q2 | $22M | Buy |
598,650
+718
| +0.1% | +$27.9K | 1.05% | 24 |
|
|
2023
Q1 | $24.4M | Buy |
597,932
+16,737
| +3% | +$723K | 1.25% | 17 |
|
|
2022
Q4 | $29.8M | Sell |
581,195
-59
| -0% | -$2.83K | 1.62% | 13 |
|
|
2022
Q3 | $25.4M | Sell |
581,254
-1,243
| -0.2% | -$60.4K | 1.42% | 12 |
|
|
2022
Q2 | $30.5M | Sell |
582,497
-2,046
| -0.4% | -$104K | 1.6% | 11 |
|
|
2022
Q1 | $30.3M | Buy |
584,543
+4,828
| +0.8% | +$251K | 1.35% | 15 |
|
|
2021
Q4 | $34.2M | Buy |
579,715
+2,766
| +0.5% | +$137K | 1.54% | 12 |
|
|
2021
Q3 | $24.8M | Sell |
576,949
-19,450
| -3% | -$862K | 1.14% | 20 |
|
|
2021
Q2 | $23.4M | Sell |
596,399
-5,586
| -0.9% | -$217K | 1.04% | 24 |
|
|
2021
Q1 | $21.8M | Sell |
601,985
-7,371
| -1% | -$262K | 1.02% | 25 |
|
|
2020
Q4 | $22.4M | Sell |
609,356
-42,439
| -7% | -$1.56M | 1.11% | 21 |
|
|
2020
Q3 | $22.7M | Buy |
651,795
+10,740
| +2% | +$377K | 1.56% | 15 |
|
|
2020
Q2 | $19.9M | Sell |
641,055
-5,358
| -0.8% | -$182K | 1.14% | 21 |
|
|
2020
Q1 | $20M | Sell |
646,413
-2,453
| -0.4% | -$83.6K | 1.35% | 14 |
|
|
2019
Q4 | $24.1M | Buy |
648,866
+5,431
| +0.8% | +$193K | 1.31% | 18 |
|
|
2019
Q3 | $21.9M | Sell |
643,435
-9,436
| -1% | -$343K | 1.07% | 19 |
|
|
2019
Q2 | $26.8M | Buy |
652,871
+1,156
| +0.2% | +$45.9K | 1.29% | 14 |
|
|
2019
Q1 | $26.3M | Sell |
651,715
-5,014
| -0.8% | -$201K | 1.25% | 14 |
|
|
2018
Q4 | $27.2M | Sell |
656,729
-12,905
| -2% | -$536K | 1.44% | 11 |
|
|
2018
Q3 | $28M | Buy |
669,634
+1,827
| +0.3% | +$70.3K | 1.18% | 15 |
|
|
2018
Q2 | $23M | Buy |
667,807
+5,611
| +0.8% | +$192K | 1.07% | 16 |
|
|
2018
Q1 | $22.3M | Buy |
662,196
+3,621
| +0.5% | +$124K | 1.09% | 21 |
|
|
2017
Q4 | $22.6M | Buy |
658,575
+2,037
| +0.3% | +$69.5K | 1.04% | 20 |
|
|
2017
Q3 | $22.2M | Sell |
656,538
-216,507
| -25% | -$6.96M | 1.16% | 18 |
|
|
2017
Q2 | $27.8M | Buy |
873,045
+4,436
| +0.5% | +$140K | 1.51% | 12 |
|
|
2017
Q1 | $28.2M | Buy |
868,609
+604
| +0.1% | +$19K | 1.5% | 12 |
|
|
2016
Q4 | $26.7M | Sell |
868,005
-7,429
| -0.8% | -$227K | 1.46% | 15 |
|
|
2016
Q3 | $28.1M | Sell |
875,434
-4,114
| -0.5% | -$138K | 1.57% | 14 |
|
|
2016
Q2 | $29.4M | Sell |
879,548
-8,816
| -1% | -$281K | 1.73% | 11 |
|
|
2016
Q1 | $25M | Sell |
888,364
-8,776
| -1% | -$251K | 1.59% | 14 |
|
|
2015
Q4 | $27.5M | Sell |
897,140
-10,912
| -1% | -$343K | 1.76% | 12 |
|
|
2015
Q3 | $27.1M | Buy |
908,052
+7,313
| +0.8% | +$234K | 1.77% | 10 |
|
|
2015
Q2 | $28.7M | Sell |
900,739
-10,101
| -1% | -$329K | 1.58% | 14 |
|
|
2015
Q1 | $30.1M | Sell |
910,840
-1,096
| -0.1% | -$34.8K | 1.66% | 12 |
|
|
2014
Q4 | $27M | Sell |
911,936
-3,935
| -0.4% | -$113K | 1.56% | 16 |
|
|
2014
Q3 | $25.7M | Sell |
915,871
-600
| -0.1% | -$16.8K | 1.38% | 17 |
|
|
2014
Q2 | $25.8M | Buy |
916,471
+1,871
| +0.2% | +$53.3K | 1.27% | 19 |
|
|
2014
Q1 | $27.9M | Sell |
914,600
-15,379
| -2% | -$459K | 1.49% | 16 |
|
|
2013
Q4 | $27M | Sell |
929,979
-1,475
| -0.2% | -$42.9K | 1.49% | 15 |
|
|
2013
Q3 | $25.4M | Sell |
931,454
-4,060
| -0.4% | -$110K | 1.52% | 14 |
|
|
2013
Q2 | $24.9M | Buy |
+935,514
| New | +$25.8M | 1.58% | 14 |
|
Other funds holding PFE
Ingalls & Snyder LLC's PFE Position: Q2 2026 in Review
Ingalls & Snyder LLC increased its Pfizer (PFE) stake by 3.1% in Q2 2026, buying an estimated $582K and bringing the position to 730,345 shares worth $17.6M. The position accounts for 0.48% of the portfolio, ranked #43.
Ingalls & Snyder LLC first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $34.2M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Ingalls & Snyder LLC held 730,345 shares of Pfizer worth $17.6M as of Q2 2026.
- Ingalls & Snyder LLC bought 22,248 Pfizer shares in Q2 2026, an estimated $582K.
- Pfizer made up 0.48% of Ingalls & Snyder LLC's portfolio in Q2 2026, its #43 holding.
- Ingalls & Snyder LLC first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Ingalls & Snyder LLC's Pfizer position peaked at $34.2M in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Ingalls & Snyder LLC's 13F filing for Q2 2026, filed 14 Aug 2026.